cefotiam has been researched along with sulbactam in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chifu, S; Ebihara, M; Fukunaga, H; Furuno, T; Genka, K; Harada, Y; Hiraoka, T; Hirota, N; Inuyama, M; Ishibashi, T; Iwanaga, T; Kisanuki, K; Kishikawa, R; Makie, T; Matsukizono, K; Matsuura, Y; Mitsuno, T; Namba, K; Oe, T; Shimazu, K; Sugiyama, M; Takamoto, M; Tsumori, Y; Tsurutani, H; Ueno, Y | 1 |
Dehne, MG; Hempelmann, G; Mühling, J; Nopens, H; Sablotzki, A | 1 |
Abe, T; Sato, Y; Sei, M | 1 |
2 trial(s) available for cefotiam and sulbactam
Article | Year |
---|---|
[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Ampicillin; Aspartate Aminotransferases; Cefotiam; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Pneumonia, Bacterial; Sulbactam; Treatment Outcome | 1998 |
Pharmacokinetics of antibiotic prophylaxis in major orthopedic surgery and blood-saving techniques.
Topics: Aged; Ampicillin; Antibiotic Prophylaxis; Blood Transfusion, Autologous; Bone and Bones; Cefamandole; Cefotiam; Cefuroxime; Cephalosporins; Drug Monitoring; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Male; Metabolic Clearance Rate; Middle Aged; Orthopedic Procedures; Risk Factors; Sulbactam; Time Factors; Tissue Distribution | 2001 |
1 other study(ies) available for cefotiam and sulbactam
Article | Year |
---|---|
[Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cefoperazone; Cefotiam; Drug Resistance, Bacterial; Humans; Japan; Sulbactam; Time Factors | 2003 |